Insider Trading activities at Celldex Therapeutics, Inc. (CLDX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celldex Therapeutics, Inc. (CLDX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Celldex Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 744218.

Total stock buying since 2015: $906,022.
Total stock sales since 2015: $11,528,594.
Total stock option exercises since 2015: $2,831,887.


12 insiders reported insider trading activities at Celldex Therapeutics, Inc. (CLDX):
Insider trading activities of Martin Samuel Bates
Insider trading activities of Wright Richard M.
Insider trading activities of Young Diane C.
Insider trading activities of Ellberger Larry
Insider trading activities of Marucci Anthony S
Insider trading activities of Cavanaugh Sarah
Insider trading activities of Keler Tibor
Insider trading activities of Crowley Elizabeth
Insider trading activities of Marino James J
Insider trading activities of Heath-chiozzi Margo
Insider trading activities of Catlin Avery W
Insider trading activities of Jimenez Freddy A.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Celldex Therapeutics, Inc. (CLDX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 771 $19,030 0 $0
2024 11,500 $308,430 60,000 $2,112,705 63,706 $427,676
2022 0 $0 155,328 $5,812,910 155,328 $992,474
2021 430 $19,900 50,501 $2,131,578 80,552 $664,479
2020 42,220 $133,586 20,832 $387,621 20,832 $122,867
2018 56,500 $28,984 0 $0 0 $0
2016 3,000 $9,960 0 $0 47,847 $153,391
2015 25,800 $405,162 50,000 $1,064,750 60,000 $471,000

Table 2. Monthly summary of insider trading at Celldex Therapeutics, Inc. (CLDX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 0 $0 771 $19,030 0 $0
2024-11 11,500 $308,430 0 $0 0 $0
2024-06 0 $0 60,000 $2,112,705 39,540 $285,145
2024-02 0 $0 0 $0 24,166 $142,531
2022-08 0 $0 155,328 $5,812,910 155,328 $992,474
2021-12 0 $0 21,423 $875,920 18,923 $150,039
2021-11 0 $0 26,340 $1,131,764 26,711 $149,611
2021-08 430 $19,900 2,738 $123,894 34,918 $364,829
2020-12 0 $0 20,832 $387,621 20,832 $122,867
2020-06 42,220 $133,586 0 $0 0 $0
2018-08 40,000 $19,200 0 $0 0 $0
2018-06 16,500 $9,784 0 $0 0 $0
2016-09 3,000 $9,960 0 $0 10,000 $28,000
2016-06 0 $0 0 $0 22,847 $83,391
2016-03 0 $0 0 $0 15,000 $42,000
2015-11 0 $0 25,000 $450,000 25,000 $213,000
2015-09 0 $0 0 $0 10,000 $45,000
2015-08 25,800 $405,162 0 $0 0 $0
2015-06 0 $0 25,000 $614,750 25,000 $213,000

Table 3. Detailed insider trading at Celldex Therapeutics, Inc. (CLDX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-13 Jimenez Freddy A. (SVP & GENERAL COUNSEL) Sale 771 24.68 19,030
2024-11-11 Marucci Anthony S (PRESIDENT & CEO) Buy 11,500 26.82 308,430
2024-06-11 Young Diane C. (SVP, CHIEF MEDICAL OFFICER) Option Ex 15,000 2.71 40,650
2024-06-07 Crowley Elizabeth (SR. VP & CPDO) Sale 15,000 35.06 525,870
2024-06-07 Crowley Elizabeth (SR. VP & CPDO) Option Ex 15,000 9.70 145,470
2024-06-07 Young Diane C. (SVP, CHIEF MEDICAL OFFICER) Sale 45,000 35.26 1,586,835
2024-06-05 Jimenez Freddy A. (SVP & GENERAL COUNSEL) Option Ex 9,540 10.38 99,025
2024-02-13 Jimenez Freddy A. (SVP & GENERAL COUNSEL) Option Ex 24,166 5.90 142,531
2022-08-15 Wright Richard M. (SR. VP & CCO) Sale 15,328 37.71 578,049
2022-08-15 Wright Richard M. (SR. VP & CCO) Option Ex 15,328 10.38 159,104
2022-08-15 Marucci Anthony S (PRESIDENT & CEO) Sale 120,000 37.66 4,519,560
2022-08-15 Marucci Anthony S (PRESIDENT & CEO) Option Ex 120,000 5.90 707,760
2022-08-12 Martin Samuel Bates (SVP AND CFO) Sale 17,547 35.59 624,445
2022-08-12 Martin Samuel Bates (SVP AND CFO) Option Ex 17,547 5.90 103,492
2022-08-11 Martin Samuel Bates (SVP AND CFO) Sale 2,453 37.04 90,856
2022-08-11 Martin Samuel Bates (SVP AND CFO) Option Ex 2,453 9.02 22,118
2021-12-23 Martin Samuel Bates (SVP and CFO) Sale 9,500 42.00 399,000
2021-12-23 Martin Samuel Bates (SVP and CFO) Option Ex 7,000 5.90 41,286
2021-12-08 Heath-chiozzi Margo (SVP of Regulatory Affairs) Sale 600 40.00 24,000
2021-12-08 Heath-chiozzi Margo (SVP of Regulatory Affairs) Option Ex 600 2.78 1,667
2021-12-08 Cavanaugh Sarah (SVP of Corp Affairs & Admin.) Sale 7,323 40.00 292,920
2021-12-08 Cavanaugh Sarah (SVP of Corp Affairs & Admin.) Option Ex 7,323 9.70 71,018
2021-12-08 Crowley Elizabeth (Sr. VP &CPDO) Sale 4,000 40.00 160,000
2021-12-08 Crowley Elizabeth (Sr. VP &CPDO) Option Ex 4,000 9.02 36,068
2021-11-15 Martin Samuel Bates (SVP and CFO) Sale 9,500 43.10 409,421
2021-11-15 Martin Samuel Bates (SVP and CFO) Option Ex 7,000 5.90 41,286
2021-11-12 Young Diane C. (SVP, Chief Medical Officer) Sale 4,600 42.94 197,528
2021-11-12 Young Diane C. (SVP, Chief Medical Officer) Option Ex 4,600 10.38 47,748
2021-11-01 Heath-chiozzi Margo (SVP of Regulatory Affairs) Sale 600 41.71 25,026
2021-11-01 Heath-chiozzi Margo (SVP of Regulatory Affairs) Option Ex 600 2.78 1,667
2021-11-01 Cavanaugh Sarah (SVP of Corp Affairs & Admin.) Sale 7,323 42.93 314,383
2021-11-01 Cavanaugh Sarah (SVP of Corp Affairs & Admin.) Option Ex 5,956 5.90 35,128
2021-11-01 Crowley Elizabeth (Sr. VP &CPDO) Sale 4,317 42.95 185,406
2021-11-01 Crowley Elizabeth (Sr. VP &CPDO) Option Ex 8,555 2.78 23,782
2021-08-11 Jimenez Freddy A. (SVP & General Counsel) Buy 430 46.28 19,900
2021-08-11 Heath-chiozzi Margo (SVP of Regulatory Affairs) Option Ex 10,000 9.02 90,170
2021-08-10 Martin Samuel Bates (SVP and CFO) Sale 2,738 45.25 123,894
2021-08-10 Martin Samuel Bates (SVP and CFO) Option Ex 21,381 5.90 126,105
2021-08-05 Marucci Anthony S (President & CEO) Option Ex 3,537 42.00 148,554
2020-12-14 Wright Richard M. (Sr. VP & CCO) Sale 20,832 18.61 387,621
2020-12-14 Wright Richard M. (Sr. VP & CCO) Option Ex 20,832 5.90 122,867
2020-06-11 Young Diane C. (SVP, Chief Medical Officer) Buy 2,115 4.73 10,003
2020-06-10 Cavanaugh Sarah (SVP of Corp Affairs & Admin.) Buy 1,050 4.83 5,071
2020-06-09 Heath-chiozzi Margo (SVP of Regulatory Affairs) Buy 1,000 3.00 3,005
2020-06-09 Martin Samuel Bates (SVP and CFO) Buy 9,750 3.05 29,737
2020-06-09 Marucci Anthony S (President & CEO) Buy 15,000 3.06 45,900
2020-06-09 Keler Tibor (Executive VP & CSO) Buy 5,000 2.99 14,955
2020-06-09 Marino James J Buy 8,305 3.00 24,915
2018-08-24 Marino James J Buy 40,000 .48 19,200
2018-06-15 Keler Tibor (Executive VP & CSO) Buy 16,500 .59 9,784
2016-09-02 Keler Tibor (Executive VP & CSO) Buy 3,000 3.32 9,960
2016-09-02 Catlin Avery W (Sr. VP & CFO) Option Ex 10,000 2.80 28,000
2016-06-03 Catlin Avery W (Sr. VP & CFO) Option Ex 22,847 3.65 83,391
2016-03-09 Catlin Avery W (Sr. VP & CFO) Option Ex 15,000 2.80 42,000
2015-11-23 Catlin Avery W (Sr. VP & CFO) Sale 25,000 18.00 450,000
2015-11-23 Catlin Avery W (Sr. VP & CFO) Option Ex 25,000 8.52 213,000
2015-09-11 Catlin Avery W (Sr. VP & CFO) Option Ex 10,000 4.50 45,000
2015-08-25 Ellberger Larry Buy 5,000 14.00 70,000
2015-08-20 Ellberger Larry Buy 5,000 15.00 75,000
2015-08-18 Ellberger Larry Buy 5,000 15.94 79,715
2015-08-13 Marucci Anthony S (President and CEO) Buy 5,800 16.81 97,497
2015-08-13 Ellberger Larry Buy 5,000 16.59 82,950
2015-06-15 Catlin Avery W (Sr. VP & CFO) Sale 25,000 24.59 614,750
2015-06-15 Catlin Avery W (Sr. VP & CFO) Option Ex 25,000 8.52 213,000

Insider trading activities including stock purchases, stock sales, and option exercises of CLDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Celldex Therapeutics, Inc. (symbol CLDX, CIK number 744218) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.